Preclinical assessment of the receptor-binding domain of Plasmodium vivax Duffy-binding protein as a vaccine candidate in rhesus macaques

Vaccine

Volumn 26, Issue 34, 2008, Pages 4338-4344

  Moreno, A ^a,b   Caro Aguilar, I ^a   Yazdani, S S ^c   Shakri, A R ^c   Lapp, S ^a   Strobert, E ^a   McClure, H ^a   Chitnis, C E ^c   Galinski, M R ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

Author keywords

Adjuvant formulation; Duffy binding protein; Malaria vaccine; Plasmodium vivax

Indexed keywords

ALUMINUM HYDROXIDE; AS02A; DUFFY BINDING PROTEIN; IMMUNOLOGICAL ADJUVANT; IMMUNOLOGICAL ADJUVANT AS02A; ISA 720; MALARIA VACCINE; MONTANIDE ISA 51; MONTANIDE ISA 720; PLASMODIUM VIVAX VACCINE; POLYHISTIDINE TAG; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN PVRII;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; ESCHERICHIA COLI; EX VIVO STUDY; IMMUNOGENICITY; IN VITRO STUDY; MOLECULAR RECOGNITION; NONHUMAN; PLASMODIUM VIVAX; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PURIFICATION; RECEPTOR BINDING; RHESUS MONKEY; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ALUMINUM HYDROXIDE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERFERON TYPE II; LYMPHOCYTES; MACACA MULATTA; MALARIA; MALARIA VACCINES; MANNITOL; OLEIC ACIDS; PROTEIN BINDING; PROTOZOAN PROTEINS; RECEPTORS, CELL SURFACE; VACCINES, SYNTHETIC;

EID: 47649093615     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.06.010     Document Type: Article

References (42)

1. Snow R.W., Guerra C.A., Noor A.M., Myint H.Y., and Hay S.I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434 7030 (2005) 214-217
2. Guinovart C., Navia M.M., Tanner M., and Alonso P.L. Malaria: burden of disease. Curr Mol Med 6 2 (2006) 137-140
3. Greenwood B. Malaria vaccines. Evaluation and implementation. Acta Trop 95 3 (2005) 298-304
4. Miller L.H., Mason S.J., Dvorak J.A., McGinniss M.H., and Rothman I.K. Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. Science 189 4202 (1975) 561-563
5. Barnwell J.W., Nichols M.E., and Rubinstein P. In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax. J Exp Med 169 5 (1989) 1795-1802
6. Horuk R., Chitnis C.E., Darbonne W.C., Colby T.J., Rybicki A., Hadley T.J., et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 261 5125 (1993) 1182-1184
7. Wertheimer S.P., and Barnwell J.W. Plasmodium vivax interaction with the human Duffy blood group glycoprotein: identification of a parasite receptor-like protein. Exp Parasitol 69 4 (1989) 340-350
8. Adams J.H., Sim B.K., Dolan S.A., Fang X., Kaslow D.C., and Miller L.H. A family of erythrocyte binding proteins of malaria parasites. Proc Natl Acad Sci USA 89 15 (1992) 7085-7089
9. Chitnis C.E., Chaudhuri A., Horuk R., Pogo A.O., and Miller L.H. The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes. J Exp Med 184 4 (1996) 1531-1536
10. Singh A.P., Puri S.K., and Chitnis C.E. Antibodies raised against receptor-binding domain of Plasmodium knowlesi Duffy binding protein inhibit erythrocyte invasion. Mol Biochem Parasitol 121 1 (2002) 21-31
11. Dutta S., Daugherty J.R., Ware L.A., Lanar D.E., and Ockenhouse C.F. Expression, purification and characterization of a functional region of the Plasmodium vivax Duffy binding protein. Mol Biochem Parasitol 109 2 (2000) 179-184
12. Michon P., Fraser T., and Adams J.H. Naturally acquired and vaccine-elicited antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding protein. Infect Immun 68 6 (2000) 3164-3171
13. Singh S.K., Hora R., Belrhali H., Chitnis C.E., and Sharma A. Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain. Nature 439 7077 (2006) 741-744
14. Xainli J., Cole-Tobian J.L., Baisor M., Kastens W., Bockarie M., Yazdani S.S., et al. Epitope-specific humoral immunity to Plasmodium vivax Duffy binding protein. Infect Immun 71 5 (2003) 2508-2515
15. Yazdani S.S., Shakri A.R., Mukherjee P., Baniwal S.K., and Chitnis C.E. Evaluation of immune responses elicited in mice against a recombinant malaria vaccine based on Plasmodium vivax Duffy binding protein. Vaccine 22 27-28 (2004) 3727-3737
16. Chitnis C.E., and Miller L.H. Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J Exp Med 180 2 (1994) 497-506
17. Singh S., Pandey K., Chattopadhayay R., Yazdani S.S., Lynn A., Bharadwaj A., et al. Biochemical, biophysical, and functional characterization of bacterially expressed and refolded receptor binding domain of Plasmodium vivax Duffy-binding protein. J Biol Chem 276 20 (2001) 17111-17116
18. Yazdani S.S., Shakri A.R., Pattnaik P., Rizvi M.M., and Chitnis C.E. Improvement in yield and purity of a recombinant malaria vaccine candidate based on the receptor-binding domain of Plasmodium vivax Duffy binding protein by codon optimization. Biotechnol Lett 28 14 (2006) 1109-1114
19. Arevalo-Herrera M., Castellanos A., Yazdani S.S., Shakri A.R., Chitnis C.E., Dominik R., et al. Immunogenicity and protective efficacy of recombinant vaccine based on the receptor-binding domain of the Plasmodium vivax Duffy binding protein in Aotus monkeys. Am J Trop Med Hyg 73 5 Suppl (2005) 25-31
20. Yazdani S.S., Shakri A.R., and Chitnis C.E. A high cell density fermentation strategy to produce recombinant malarial antigen in E. coli. Biotechnol Lett 26 24 (2004) 1891-1895
21. Devi Y.S., Mukherjee P., Yazdani S.S., Shakri A.R., Mazumdar S., Pandey S., et al. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice. Vaccine 25 28 (2007) 5166-5174
22. Choe H., Moore M.J., Owens C.M., Wright P.L., Vasilieva N., Li W., et al. Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen/receptor for chemokines (DARC). Mol Microbiol 55 5 (2005) 1413-1422
23. Jennes W., Kestens L., Nixon D.F., and Shacklett B.L. Enhanced ELISPOT detection of antigen-specific T cell responses from cryopreserved specimens with addition of both IL-7 and IL-15-the Amplispot assay. J Immunol Methods 270 1 (2002) 99-108
24. Gilberger T.W., Thompson J.K., Triglia T., Good R.T., Duraisingh M.T., and Cowman A.F. A novel erythrocyte binding antigen-175 paralogue from Plasmodium falciparum defines a new trypsin-resistant receptor on human erythrocytes. J Biol Chem 278 16 (2003) 14480-14486
25. Mayer D.C., Kaneko O., Hudson-Taylor D.E., Reid M.E., and Miller L.H. Characterization of a Plasmodium falciparum erythrocyte-binding protein paralogous to EBA-175. Proc Natl Acad Sci USA 98 9 (2001) 5222-5227
26. Pandey K.C., Singh S., Pattnaik P., Pillai C.R., Pillai U., Lynn A., et al. Bacterially expressed and refolded receptor binding domain of Plasmodium falciparum EBA-175 elicits invasion inhibitory antibodies. Mol Biochem Parasitol 123 1 (2002) 23-33
27. Narum D.L., Haynes J.D., Fuhrmann S., Moch K., Liang H., Hoffman S.L., et al. Antibodies against the Plasmodium falciparum receptor binding domain of EBA-175 block invasion pathways that do not involve sialic acids. Infect Immun 68 4 (2000) 1964-1966
28. Grimberg B.T., Udomsangpetch R., Xainli J., McHenry A., Panichakul T., Sattabongkot J., et al. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS Med 4 12 (2007) e337
29. Stewart V.A., McGrath S.M., Walsh D.S., Davis S., Hess A.S., Ware L.A., et al. Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS, S/AS02A. Vaccine 24 42-43. (2006) 6483-6492
30. Pichyangkul S., Kum-Arb U., Yongvanitchit K., Limsalakpetch A., Gettayacamin M., Lanar D.E., et al. Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS, S/AS01B vaccine in rhesus primates. Infect Immun 76 1 (2008) 229-238
31. Gibbs R.A., Rogers J., Katze M.G., Bumgarner R., Weinstock G.M., Mardis E.R., et al. Evolutionary and biomedical insights from the rhesus macaque genome. Science 316 5822 (2007) 222-234
32. Collins W.E. South American monkeys in the development and testing of malarial vaccines-a review. Mem Inst Oswaldo Cruz 87 Suppl 3 (1992) 401-406
33. Dutta S., Kaushal D.C., Ware L.A., Puri S.K., Kaushal N.A., Narula A., et al. Merozoite surface protein 1 of Plasmodium vivax induces a protective response against Plasmodium cynomolgi challenge in rhesus monkeys. Infect Immun 73 9 (2005) 5936-5944
34. Fraser T., Michon P., Barnwell J.W., Noe A.R., Al-Yaman F., Kaslow D.C., et al. Expression and serologic activity of a soluble recombinant Plasmodium vivax Duffy binding protein. Infect Immun 65 7 (1997) 2772-2777
35. Michon P.A., Arevalo-Herrera M., Fraser T., Herrera S., and Adams J.H. Serologic responses to recombinant Plasmodium vivax Duffy binding protein in a Colombian village. Am J Trop Med Hyg 59 4 (1998) 597-599
36. Ceravolo I.P., Bruna-Romero O., Braga E.M., Fontes C.J., Brito C.F., Souza J.M., et al. Anti-Plasmodium vivax Duffy binding protein antibodies measure exposure to malaria in the Brazilian Amazon. Am J Trop Med Hyg 72 6 (2005) 675-681
37. Tran T.M., Oliveira-Ferreira J., Moreno A., Santos F., Yazdani S.S., Chitnis C.E., et al. Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population. Am J Trop Med Hyg 73 2 (2005) 244-255
38. Cole-Tobian J.L., Cortes A., Baisor M., Kastens W., Xainli J., Bockarie M., et al. Age-acquired immunity to a Plasmodium vivax invasion ligand, the Duffy binding protein. J Infect Dis 186 4 (2002) 531-539
39. Xainli J., Baisor M., Kastens W., Bockarie M., Adams J.H., and King C.L. Age-dependent cellular immune responses to Plasmodium vivax Duffy binding protein in humans. J Immunol 169 6 (2002) 3200-3207
40. Bejon P., Kai O.K., Mwacharo J., Keating S., Lang T., Gilbert S.C., et al. Alternating vector immunizations encoding pre-erythrocytic malaria antigens enhance memory responses in a malaria endemic area. Eur J Immunol 36 8 (2006) 2264-2272
41. Keating S.M., Bejon P., Berthoud T., Vuola J.M., Todryk S., Webster D.P., et al. Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria. J Immunol 175 9 (2005) 5675-5680
42. Flanagan K.L., Lee E.A., Gravenor M.B., Reece W.H., Urban B.C., Doherty T., et al. T cell effector functions elicited by Plasmodium falciparum epitopes in malaria-exposed Africans tested by three T cell assays. J Immunol 167 8 (2001) 4729-4737